7-PHENYL SUBSTITUTED 2-AMINOQUINAZOLINE INHIBITORS OF HPK1

Compounds of the following formula (I); or the pharmaceutically acceptable salts thereof, are inhibitors of haematopoietic progenitor kinase 1 (HPK1) useful in the treatment of diseases or disorders associated with HPK1. Also disclosed herein are uses of these compounds in the potential treatment or...

Full description

Saved in:
Bibliographic Details
Main Authors CHEN, Joanna, NAIR, Anilkumar, FRADERA, Xavier, PASTERNAK, Alexander, FULLER, Peter, YU, Elsie, LI, Bing, LIM, Jongwon, CANDITO, David, DONOFRIO, Anthony, METHOT, Joey, KAWAMURA, Shuhei, LIU, Ping, VARA, Brandon
Format Patent
LanguageEnglish
French
Published 12.05.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Compounds of the following formula (I); or the pharmaceutically acceptable salts thereof, are inhibitors of haematopoietic progenitor kinase 1 (HPK1) useful in the treatment of diseases or disorders associated with HPK1. Also disclosed herein are uses of these compounds in the potential treatment or prevention of an HPK1-associated disease or disorder. Also disclosed herein are compositions comprising one or more of the compounds. Further disclosed herein are uses of these compositions in the potential prevention or treatment of an HPK1-associated disease or disorder. Les composés de la formule suivante (I) ; ou leurs sels pharmaceutiquement acceptables, sont des inhibiteurs de l'haematopoietic progenitor kinase 1 (HPK1) utiles dans le traitement de maladies ou de troubles associés à HPK1. L'invention concerne également des utilisations de ces composés dans la prévention ou le traitement potentiel d'un trouble ou d'une maladie associée à HPK1. L'invention concerne également des compositions comprenant un ou plusieurs des composés. L'invention concerne en outre des utilisations de ces compositions dans le traitement ou la prévention potentielle d'un trouble ou d'une maladie associée à HPK1.
Bibliography:Application Number: WO2021US57968